|
|
 |
|
Viewing report
|
|
|
|
Industry Report Card: U.S. Health Care Jun 02
Standard & Poors, June 2002
Abstract
Relatively favorable credit-rating activity since early March primarily reflected buoyant demand and pricing for health care services. Company-specific issues for pharmaceutical firms led to mixed credit activity in that area of health care. Overall, rating upgrades slightly exceeded downgrades over the past several months. However, this was in contrast to the preponderance of credit-quality slippage for corporate credits worldwide, which was highlighted by downgrades dwarfing upgrades by a ratio of four to one. The U.S. health-care service sector is continuing to benefit from an uptrend in fees from government and managed-care payors. Most recently, operating improvements, together with reimbursement relief, contributed to the rating upgrade for DaVita, an operator of kidney dialysis centers; positive outlooks were posted for LifePoint, a...
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.
|
|
|
|
